- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/00 - Drugs for dermatological disorders
Patent holdings for IPC class A61P 17/00
Total number of patents in this class: 9213
10-year publication summary
|
356
|
326
|
543
|
577
|
777
|
732
|
794
|
740
|
635
|
51
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shiseido Company, Ltd. | 3964 |
120 |
| Galderma Research & Development | 417 |
95 |
| AMOREPACIFIC Corporation | 2777 |
64 |
| Osaka University | 3296 |
51 |
| Novartis AG | 11276 |
48 |
| Daiichi Sankyo Company, Limited | 1863 |
48 |
| Incyte Corporation | 962 |
45 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
42 |
| Sol-gel Technologies Ltd. | 169 |
42 |
| L' Oréal | 5305 |
42 |
| The Regents of the University of California | 19503 |
41 |
| Boehringer Ingelheim International GmbH | 4751 |
40 |
| ELC Management LLC | 1043 |
40 |
| Pierre Fabre Dermo-Cosmetique | 429 |
39 |
| Kao Corporation | 4914 |
37 |
| Mitsubishi Tanabe Pharma Corporation | 576 |
36 |
| Takeda Pharmaceutical Company Limited | 2945 |
34 |
| Galderma S.A. | 159 |
34 |
| Allergan, Inc. | 2441 |
33 |
| Regeneron Pharmaceuticals, Inc. | 3980 |
32 |
| Other owners | 8250 |